Evidence map›Paper›PMID 38792134›Full record

ArticleMolecules (Basel, Switzerland)2024

C(sp)-C(sp) Lever-Based Targets of Orientational Chirality: Design and Asymmetric Synthesis.

Ting Xu, Jia-Yin Wang, Yu Wang, Shengzhou Jin, Yao Tang, Sai Zhang, Qingkai Yuan, Hao Liu, Wenxin Yan, Yinchun Jiao and 2 more

Abstract read
In one paragraph

Article in Molecules (Basel, Switzerland), 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed.

  1. Article
  2. Amino Turbo Chirality and Its Asymmetric Control.Research (Washington, D.C.) · 2024
    Article
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors.

Ting XuSchool of Chemistry and Chemical Engineering, Nanjing University, Nanjing 210093, China.ORCID 0009-0009-7895-2611
Jia-Yin WangContinuous Flow Engineering Laboratory of National Petroleum and Chemical Industry, School of Pharmacy, Changzhou University, Changzhou 213164, China.ORCID 0009-0002-3696-8657
Yu WangSchool of Chemistry and Chemical Engineering, Nanjing University, Nanjing 210093, China.
Shengzhou JinSchool of Chemistry and Chemical Engineering, Nanjing University, Nanjing 210093, China.
Yao TangDepartment of Chemistry and Biochemistry, Texas Tech University, Lubbock, TX 79409-1061, USA.
Sai ZhangDepartment of Chemistry and Biochemistry, Texas Tech University, Lubbock, TX 79409-1061, USA.
Qingkai YuanDepartment of Chemistry and Biochemistry, Texas Tech University, Lubbock, TX 79409-1061, USA.
Hao LiuDepartment of Chemistry and Biochemistry, Texas Tech University, Lubbock, TX 79409-1061, USA.
Wenxin YanKey Laboratory of Theoretical Organic Chemistry and Functional Molecular, Ministry of Education, School of Chemistry and Chemical Engineering, Hunan University of Science and Technology, Xiangtan 411201, China.
Yinchun JiaoKey Laboratory of Theoretical Organic Chemistry and Functional Molecular, Ministry of Education, School of Chemistry and Chemical Engineering, Hunan University of Science and Technology, Xiangtan 411201, China.
Xiao-Liang YangSchool of Chemistry and Chemical Engineering, Nanjing University, Nanjing 210093, China.
Guigen LiSchool of Chemistry and Chemical Engineering, Nanjing University, Nanjing 210093, China.

Funding

National Natural Science Foundation of China 22071102 and 91956110Welch Foundation D-1361-20210327
6 · The paper itself

Abstract

In this study, the design and asymmetric synthesis of a series of chiral targets of orientational chirality were conducted by taking advantage of

Indexed as

atropisomerismN-sulfinylimineorientational chiralitySonogashira coupling

Identifiers

PMID38792134
PMCPMC11123770

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.